ELEVATION WEALTH PARTNERS, LLC

Position in JNJ — Johnson & Johnson

CIK 1976256 WALNUT CREEK, CA

Position in JNJ

as of Jun 30, 2026 · filed Jul 8, 2026 Compact

Position Value

$1,612,201

+$902,103 QoQ

Shares Held

6,348

+118.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.80%

of 13F equity value

Holder Rank

#2,530

of 4,664 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

ELEVATION WEALTH PARTNERS, LLC holds $5,335,672 across 14 Drug Manufacturers - General names. JNJ ranks #2 (30.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,388	$1,664,808
2	JNJ	Johnson & Johnson This page	6,348	$1,612,201
3	ABBV	AbbVie Inc.	5,109	$1,285,628
4	MRK	Merck & Co., Inc.	2,212	$284,242
5	GILD	Gilead Sciences, Inc.	1,235	$156,029
6	AMGN	Amgen Inc	315	$114,067
7	BMY	Bristol Myers Squibb Co	1,417	$81,647
8	BIIB	Biogen Inc.	223	$48,181

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,612,201	6,348	+118.5%	Shares	Sole	2026-07-08
2026-03-31	$710,098	2,905	-4.5%	Shares	Sole	2026-04-14
2025-12-31	$629,334	3,041	-17.8%	Shares	Sole	2026-01-09
2025-09-30	$685,683	3,698	-8.1%	Shares	Sole	2025-10-14
2025-06-30	$614,971	4,026	-9.3%	Shares	Sole	2025-07-08
2025-03-31	$735,997	4,438	-4.0%	Shares	Sole	2025-04-09
2024-12-31	$668,289	4,621	-7.9%	Shares	Sole	2025-01-29
2024-09-30	$813,055	5,017	-4.2%	Shares	Sole	2024-10-04
2024-06-30	$765,732	5,239	-4.5%	Shares	Sole	2024-07-09
2024-03-31	$867,513	5,484	-22.0%	Shares	Sole	2024-04-19
2023-12-31	$1,102,195	7,032	+780.1%	Shares	Sole	2024-01-17
2023-09-30	$124,444	799	+0.5%	Shares	Sole	2023-10-10
2023-06-30	$131,588	795	0.0%	Shares	Sole	2023-07-06
2023-03-31	$123,225	795	—	Shares	Sole	2023-05-04
No filing history on record for this holder in this stock.